CLLAN Charter

About the CLLAN Charter

CLL Support is pleased to have contributed to the development of the CLL Charter. The Charter was published by CLLAN – The international CLL Advocates Network and funded by AstraZeneca.

The Charter sets out the six core principles that define what good care should look like for anyone affected by CLL. It highlights key aspects of care that can be overlooked – such as timely and accurate diagnosis, access to understandable and tailored information, shared decision-making, emotional and psychological support, and comprehensive care that addresses the full impact of the disease, including its complications and long-term effects.

The purpose of this Charter is to provide a unified, patient-centred framework that can guide improvements in CLL care around the world. It is designed to inform policy discussions, support advocacy efforts, shape national cancer plans, and serve as a benchmark for healthcare providers and systems.

Within the UK the health systems that are in place would comply with six core principles of the Charter. However, the Charter acts as a standard by which CLL should be managed. Going forward, the Charter will serve as a reference point for patients, patient groups, clinicians, and decision-makers to advocate for systemic changes that ensure all people living with CLL – regardless of geography or background – receive the support, information, and care they need to live well with their diagnosis. Read the full charter here.